Medicines Discovery Catapult (MDC) is enabling the community to reshape medicines discovery in the UK. It is ambitious, and it is achievable.
We do this by championing innovative life science technology and new approaches, supporting UK innovators to succeed.
We are helping to industrialise and drive the adoption of new techniques and technologies.
We are driven by helping our community make their mark on the industry and patients.If you’re involved with medicines discovery in the UK, MDC can almost certainly assist you. Our impact is measured by your success.
Accelerated and more efficient drug discovery in psychiatry – the impetus behind a year of upcoming activity between the Psychiatry Consortium and BNA
Psychiatric drug discovery must be a truly collaborative process if it is to be successful. To enable a more unified approach, we need a better
MDC Lighthouse Lab Partner With Levenshulme All-Girl School For British Science Week to Inspire Students into Industry
While student perceptions of careers in science may come with a lack of diversity, the Covid-19 pandemic has highlighted the important contributions made by scientists
Medicines Discovery Catapult’s newly appointed Chief Business Officer, Dr Nicola Heron MBA sets out her intention to support up-and-coming innovators in early stage drug discovery